Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

RE:RE:RE:RE:RE:Theralase Is still Flying Under the Radar

Good post CancerSlayer. Puts things in perspective. CancerSlayer wrote...

July 9, 2022

V.TLT

RE:RE:RE:Theralase Is still Flying Under the Radar

To be fair to Dr. Kamat, his role as a member of Theralase's Medical and...

July 9, 2022

V.TLT

RE:RE:Theralase Is still Flying Under the Radar

The other drugs he mentioned haven't been approved yet either, although...

July 8, 2022

V.TLT

Theralase Is still Flying Under the Radar

I guess the 29 cent stock price is a pretty good clue. TLD-1433 as a...

July 8, 2022

V.TLT

Researchers in China Acknowledge TLD1433 Safety and Efficacy

"TLD1433, a Ru (II) polypyridyl complexes, is a novel photosensitizer...

July 5, 2022

V.TLT

The Last Year of Dr. McFarland's 3 Year NSF Grant Research

Dr. McFarland's research is now focussed on combined PDT and PTT...

June 30, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:Maintenance Dose

Hi Pandora - yes, the 41 patients mentioned in Tuesday's news release...

June 30, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:Maintenance Dose

Hi Pandora - all of the first 12 patients were undertreated in their first...

June 30, 2022

V.TLT

RE:RE:RE:RE:RE:Maintenance Dose

4 of the 7 who received a second treatment received the optimized treatment. ...

June 30, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:AGM

Thanks for the update Jaro. What was the tone of the meeting? Upbeat? Neutral...

June 29, 2022

V.TLT

RE:RE:RE:RE:RE:A little movement on a patent

Hi Pandora - What I posted was just a link to a SPIE presentation. I'm...

June 27, 2022

V.TLT

Springer Handbook of Inorganic Photochemistry pp 1015–1033

It costs $30 US to download this chapter. The Google search results include...

June 27, 2022

V.TLT

RE:RE:RE:A little movement on a patent

A new platform technology RuVaCare, an extracorporeal anti-cancer vaccine is...

June 27, 2022

V.TLT

RE:RE:RE:RE:Big pharmas are watching us closely!

Theralase's treatment destroys tumours completely, and that safely...how...

June 27, 2022

V.TLT

RE:RE:A little movement on a patent

Looks like Ruvacare, Theralase's anti-cancer vaccine. FGPstock wrote...

June 27, 2022

V.TLT

Theralase Public Relations & Investor Relations Coordinator

Theralase has hired a new Public Relations & Investor Relations...

June 24, 2022

V.TLT

RE:RE:RE:RE:It' could be that they are waiting for---

We should have had 180 day results for the first 25 in March, 270 day results...

June 23, 2022

V.TLT

RE:RE:It' could be that they are waiting for---

As of Aug 30 2021, 24 patients had been treated. Theralase planned to treat...

June 23, 2022

V.TLT

Blast from the past - Theralase's Intellectual Property

There as been an explosion of new research into oncological photodynamic...

June 22, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:Employee reviews

Thanks for that, ScienceFirst. That's very interesting research. But...

June 20, 2022

Featured Company